Clinical Trial Update: Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome [Phase 1]

View source ↗

Summary

Phase 1 trial of pyrimethamine for autoimmune lymphoproliferative syndrome has completed, sponsored by the National Institute of Allergy and Infectious Diseases…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Lymphoproliferative Syndrome

Drugs mentioned

• Pyrimethamine (Pyrimethamine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Autoimmune Disease, Lymphatic Disease | Phase 1 | Status: COMPLETED